GCH1: A GPCR Involved in Cell-cell Signaling and Stress Regulation

Target Name: GCH1

NCBI ID: G2643

GCH1

GCH1: A GPCR Involved in Cell-cell Signaling and Stress Regulation

GCH1 (DYT5) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and lungs. It is a member of the G protein-coupled receptor (GPCR) family, which is a large family of transmembrane proteins that play a critical role in cellular signaling. GCH1 is unique among its family members because it is a GPCR that is highly targeted to specific intracellular signaling pathways.

One of the key functions of GCH1 is its role in cell-cell signaling. GCH1 is involved in the regulation of cell-cell interactions, including the formation of tight junctions between epithelial cells and the regulation of cell adhesion. This is important for various physiological processes, including tissue repair and regeneration, and is also involved in diseases such as cancer.

In addition to its role in cell-cell signaling, GCH1 is also involved in the regulation of ion channels and intracellular signaling pathways. It is a potent inhibitor of the protein kinase PDK4, which is involved in a variety of cellular processes, including cell growth , differentiation, and survival. This is important because abnormal activation of PDK4 has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

GCH1 is also involved in the regulation of cellular responses to stress and in the regulation of cellular signaling pathways that are involved in the inflammatory response. It is a potent inhibitor of the transcription factor Nrf2, which is involved in the regulation of DNA damage repair and stress responses. This is important because chronic exposure to stress and inflammation can lead to the development of diseases such as neuroinflammatory disorders and cancer.

GCH1 is also involved in the regulation of cellular signaling pathways that are involved in cell survival and proliferation. It is a potent inhibitor of the protein kinase B-cell src/FAK, which is involved in the regulation of cell growth, survival, and angiogenesis . This is important because chronic exposure to stress and inflammation can lead to the development of diseases such as cancer, and the ability of cells to survive and grow is a critical factor in this process.

GCH1 is also involved in the regulation of cellular signaling pathways that are involved in the regulation of cellular adhesion and migration. It is a potent inhibitor of the protein Integrin alpha-2 (ITGA2), which is involved in the regulation of cell adhesion and migration. . This is important because the regulation of cell adhesion and migration is critical for the development and maintenance of tissues and organs, and is also important for diseases such as cancer.

In conclusion, GCH1 (DYT5) is a protein that is involved in a variety of cellular signaling pathways that are critical for the development and maintenance of tissues and organs. Its unique role in cell-cell signaling and its involvement in the regulation of cellular responses to stress and inflammation make it an attractive drug target and a potential biomarker for a variety of diseases. Further research is needed to fully understand the functions of GCH1 and its potential as a drug.

Protein Name: GTP Cyclohydrolase 1

Functions: Positively regulates nitric oxide synthesis in umbilical vein endothelial cells (HUVECs). May be involved in dopamine synthesis. May modify pain sensitivity and persistence. Isoform GCH-1 is the functional enzyme, the potential function of the enzymatically inactive isoforms remains unknown

The "GCH1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GCH1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets